Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 13/20 | 1.00 |
| ▸ | CA1 | P00915 | 10/20 | 1.00 |
| ▸ | CA9 | Q16790 | 9/20 | 1.00 |
| ▸ | CA12 | O43570 | 8/20 | 1.00 |
| ▸ | CA4 | P22748 | 4/20 | 1.00 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 0.71 |
| ▸ | TSHR | P16473 | 2/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.65 |
| ▸ | F2 | P00734 | 1/20 | 0.55 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.55 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.55 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.55 |
| ▸ | CA5A | P35218 | 3/20 | 0.54 |
| ▸ | CA6 | P23280 | 2/20 | 0.54 |
| ▸ | CA7 | P43166 | 2/20 | 0.54 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5633669 | 0.98 | CA2 (0.95) | CA2CA1CA9CA12CA4 | |
| SCHEMBL7117232 | 0.87 | CA2 (0.77) | CA2CA1CA9CA12CA4 | |
| SCHEMBL2398133 | 0.85 | CA2 (1.00) | CA2CA1CA9CA12CA4 | |
| SCHEMBL27698948 | 0.84 | CA2 (0.70) | CA2CA1CA9CA12CA4 | |
| SCHEMBL5561963 | 0.83 | LMNA (1.00) | CA2CA1CA9CA12CA4 | |
| SCHEMBL29635012 | 0.83 | LMNA (1.00) | CA2CA1CA9CA12CA4 | |
| SCHEMBL34546 | 0.83 | LMNA (1.00) | CA2CA1CA9CA12CA4 | |
| SCHEMBL30544199 | 0.83 | LMNA (1.00) | CA2CA1CA9CA12CA4 | |
| Alanine SCHEMBL28513478 | 0.82 | CA1 (0.68) | CA2CA1CA9CA12CA4 | |
| SCHEMBL4347220 | 0.81 | CA1 (0.66) | CA2CA1CA9CA12CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1719 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4745119-A1 | ISOCYANATE COMPOSITION | Hanwha Solutions Corporation (KR) | 2026-05-20 | — | — | EP | claimed |
| WO-2025042219-A1 | ISOCYANATE COMPOSITION | 한화솔루션 주식회사 | 2025-02-27 | — | — | WO | claimed |
| CN-115430296-B | Composite nanofiltration membrane with catalytic intermediate layer and preparation method and application thereof | 中国科学院过程工程研究所 | 2025-02-21 | — | — | CN | claimed |
| CN-118807490-A | Composite nanofiltration membrane based on oil immersed gel coating and preparation method thereof | 中国科学院过程工程研究所 | 2024-10-22 | — | — | CN | claimed |
| CN-115869784-B | Composite nanofiltration membrane based on primary layer solvent rearrangement and catalytic activation and preparation method and application thereof | 中国科学院过程工程研究所 | 2024-09-24 | — | — | CN | claimed |
| CN-116272909-B | Rotating wheel dehumidifier core material and preparation method thereof | 集美大学 | 2024-07-05 | — | — | CN | claimed |
| CN-114614058-B | Thin-layer composite proton exchange membrane and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-117069627-A | 4- (3- (3-sulfamoyl phenyl) ureido) butyric acid compound, fluorescent marker, preparation method and application thereof | 上海康斯维克生物医药有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-116672886-A | Acid-resistant nanofiltration membrane sheet and manufacturing method thereof | 率氢技术(北京)股份有限公司 | 2023-09-01 | — | — | CN | claimed |
| CN-116396193-A | Method for preparing alpha-sulfonamido acetals from fatty aldehydes and sulfonamides | 西北工业大学 | 2023-07-07 | — | — | CN | claimed |
| EP-1773768-A2 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | Exelixis, Inc. (US) | 2007-04-18 | — | — | EP | claimed |
| WO-2007041634-A1 | PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS | AVENTIS PHARMACEUTICALS INC. (US) | 2007-04-12 | — | — | WO | claimed |
| EP-1761541-A1 | PYRRAZOLO-PYRIMIDINE DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2007-03-14 | — | — | EP | claimed |
| WO-2007020046-A1 | BENZOQUINAZOLINE DERIVATIVES AND THEIR USE IN TREATING BONE DISORDERS | NOVARTIS AG (CH) | 2007-02-22 | — | — | WO | claimed |
| US-20060223996-A1 | IL-12 modulatory compounds | SYNTA PHARMACEUTICALS CORP. (US) | 2006-10-05 | — | — | US | claimed |
| US-20060111405-A1 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | GU LIANQUAN | 2006-05-25 | — | — | US | claimed |
| WO-2006053227-A2 | IL-12 MODULATORY COMPOUNDS | SYNTA PHARMACEUTICALS CORP. (US) | 2006-05-18 | — | — | WO | claimed |
| WO-2006012642-A2 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | EXELIXIS, INC. (US) | 2006-02-02 | — | — | WO | claimed |
| WO-2005123738-A1 | PYRRAZOLO-PYRIMIDINE DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2005-12-29 | — | — | WO | claimed |
| US-4083866-A | Sulfonylamidino aminobenzaldehyde compounds | CIBA-GEIGY CORPORATION (US) | 1978-04-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060223996-A1 | IL-12 modulatory compounds | IL2, IL4, IFNG | CA2 3151/4885CA1 2562/4885CA9 4341/4885 |
| US-20060111405-A1 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | PTGS2, PTGES2, PTGES | CA2 1743/4885CA1 4180/4885CA9 3227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.